Period of time： 2008年5期
Publisher： Future Medicine
Founded in： 2006
Total resources： 16
ISSN： 1746-0816
Subject： R5 Internal Medicine
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Future Rheumatology,volume 1,issue 5
Menu
Arthritis drug in multisystem inflammatory disease breakthrough
Future Rheumatology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-10 , pp.
Access to resources
Recommend
Nimesulide for painful osteoarthritis
Future Rheumatology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-10 , pp.Zoledronic acid: future potential use in rheumatology
Future Rheumatology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-10 , pp.Bosentan for the treatment of scleroderma
By Hachulla Eric,Launay David,Humbert Marc in (2006)
Future Rheumatology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-10 , pp.Identification of the Yaa lupus gene as a Tlr-7 gene duplication event
By Wang Andrew,Mohan Chandra in (2006)
Future Rheumatology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-10 , pp.Ultrasound in assessing disease severity and therapeutic response in rheumatoid arthritis
By Keen Helen I,Wakefield Richard J,Conaghan Philip G in (2006)
Future Rheumatology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-10 , pp.Biomarkers in osteoarthritis: a clinical trials perspective
By Jordan Joanne M,Kraus Virginia B in (2006)
Future Rheumatology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-10 , pp.T-cell-directed therapy in systemic lupus erythematosus
Future Rheumatology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-10 , pp.Risk factors for lymphoproliferation and mortality in Sjögren’s syndrome
By Voulgarelis Michael,Tzioufas Athanasios G in (2006)
Future Rheumatology,volume 1,issue 5 , Vol. 1, Iss. 5, 2006-10 , pp.
Previous
Next